Advertisement

Most Common Patient Hair Questions and Answers

  • Brandon Burroway
  • Jacob Griggs
  • Antonella TostiEmail author
Chapter

Abstract

Patients often have a number of questions regarding changes in their hair. This chapter contains the most common questions patients ask as well as the answers to these questions. The chapter discusses basic information about hair growth and loss; age-related hair problems; effect of nutrition and lifestyle choices on hair; specific diagnoses including androgenetic alopecia, alopecia areata, cicatricial alopecia, and seborrheic dermatitis; and, finally, common treatment questions.

Keywords

Hair growth Hair loss Age-related changes Graying Dryness Nutrition Supplements Smoking Sun exposure Androgenetic alopecia Alopecia areata Alopecia areata incognita Cicatricial alopecia Seborrheic dermatitis Minoxidil Platelet-rich plasma 

References

  1. 1.
    Baque CS, Zhou J, Gu W, Collaudin C, Kravtchenko S, Kempf JY, et al. Relationships between hair growth rate and morphological parameters of human straight hair: a same law above ethnical origins? Int J Cosmet Sci. 2012;34(2):111–6.  https://doi.org/10.1111/j.1468-2494.2011.00687.x.CrossRefPubMedGoogle Scholar
  2. 2.
    Loussouarn G, El Rawadi C, Genain G. Diversity of hair growth profiles. Int J Dermatol. 2005;44(s1):6–9.  https://doi.org/10.1111/j.1365-4632.2005.02800.x.CrossRefPubMedGoogle Scholar
  3. 3.
    Gray J. Hair care and hair care products. Clin Dermatol. 2001;19(2):227–36.  https://doi.org/10.1016/S0738-081X(00)00133-4.CrossRefPubMedGoogle Scholar
  4. 4.
    Sinclair R. Diffuse hair loss. Int J Dermatol. 1999;38(Suppl 1):8–18. http://www.ncbi.nlm.nih.gov/pubmed/10369535.CrossRefGoogle Scholar
  5. 5.
    Thibaut S, De Becker E, Caisey L, Baras D, Karatas S, Jammayrac O, et al. Human eyelash characterization. Br J Dermatol. 2010;162(2):304–10.  https://doi.org/10.1111/j.1365-2133.2009.09487.x.CrossRefPubMedGoogle Scholar
  6. 6.
    Na JI, Kwon OS, Kim BJ, Park WS, Oh JK, Kim KH, et al. Ethnic characteristics of eyelashes: a comparative analysis in Asian and Caucasian females. Br J Dermatol. 2006;155(6):1170–6.  https://doi.org/10.1111/j.1365-2133.2006.07495.x.CrossRefPubMedGoogle Scholar
  7. 7.
    Sinclair R. Hair shedding in women: how much is too much? Br J Dermatol. 2015;173(3):846–8.  https://doi.org/10.1111/bjd.13873.CrossRefPubMedGoogle Scholar
  8. 8.
    Martínez-Velasco MA, Vázquez-Herrera NE, Maddy AJ, Asz-Sigall D, Tosti A. The hair shedding visual scale: a quick tool to assess hair loss in women. Dermatol Ther (Heidelb). 2017;7(1):155–65.  https://doi.org/10.1007/s13555-017-0171-8.CrossRefGoogle Scholar
  9. 9.
    Ramos PM, Miot HA. Female pattern hair loss: a clinical and pathophysiological review. An Bras Dermatol. 2015;90(4):529–43.  https://doi.org/10.1590/abd1806-4841.20153370.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kunz M, Seifert B, Trüeb RM. Seasonality of hair shedding in healthy women complaining of hair loss. Dermatology. 2009;219(2):105–10.  https://doi.org/10.1159/000216832.CrossRefPubMedGoogle Scholar
  11. 11.
    Randall VA, Ebling FJ. Seasonal changes in human hair growth. Br J Dermatol. 1991;124(2):146–51.. http://www.ncbi.nlm.nih.gov/pubmed/2003996CrossRefGoogle Scholar
  12. 12.
    Mirmirani P. Age-related hair changes in men: mechanisms and management of alopecia and graying. Maturitas. 2015;80(1):58–62.  https://doi.org/10.1016/J.MATURITAS.2014.10.008.CrossRefPubMedGoogle Scholar
  13. 13.
    Akin Belli A, Etgu F, Ozbas Gok S, Kara B, Dogan G. Risk factors for premature hair graying in young turkish adults. Pediatr Dermatol. 2016;33(4):438–42.  https://doi.org/10.1111/pde.12881.CrossRefPubMedGoogle Scholar
  14. 14.
    Shin H, Ryu HH, Yoon J, Jo S, Jang S, Choi M, et al. Association of premature hair graying with family history, smoking, and obesity: a cross-sectional study. J Am Acad Dermatol. 2015;72(2):321–7.  https://doi.org/10.1016/j.jaad.2014.11.008.CrossRefPubMedGoogle Scholar
  15. 15.
    Panhard S, Lozano I, Loussouarn G. Greying of the human hair: a worldwide survey, revisiting the ‘50’ rule of thumb. Br J Dermatol. 2012;167(4):865–73.  https://doi.org/10.1111/j.1365-2133.2012.11095.x.CrossRefPubMedGoogle Scholar
  16. 16.
    Pandhi D, Khanna D. Premature graying of hair. Indian J Dermatol Venereol Leprol. 2013;79(5):641–53.  https://doi.org/10.4103/0378-6323.116733.CrossRefPubMedGoogle Scholar
  17. 17.
    Trüeb RM. Effect of ultraviolet radiation, smoking and nutrition on hair. Curr Probl Dermatol. 2015;47:107–20.  https://doi.org/10.1159/000369411.CrossRefPubMedGoogle Scholar
  18. 18.
    Fortes C, Mastroeni S, Mannooranparampil TJ, Ribuffo M. The combination of overweight and smoking increases the severity of androgenetic alopecia. Int J Dermatol. 2017;56(8):862–7.  https://doi.org/10.1111/ijd.13652.CrossRefPubMedGoogle Scholar
  19. 19.
    Trüeb RM. Is androgenetic alopecia a photoaggravated dermatosis? Dermatology. 2003;207(4):343–8.  https://doi.org/10.1159/000074111.CrossRefPubMedGoogle Scholar
  20. 20.
    Camacho F, Moreno JC, García-Hernández MJ. Telogen alopecia from UV rays. Arch Dermatol. 1996;132(11):1398.  https://doi.org/10.1001/archderm.1996.03890350142037.CrossRefPubMedGoogle Scholar
  21. 21.
    Lee W-S. Photoaggravation of hair aging. Int J Trichology. 2009;1(2):94–9.  https://doi.org/10.4103/0974-7753.58551.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Thom E. Stress and the hair growth cycle: cortisol-induced hair growth disruption. J Drugs Dermatol. 2016;15(8):1001–4. http://www.ncbi.nlm.nih.gov/pubmed/27538002. Accessed 13 Jan 2019.PubMedGoogle Scholar
  23. 23.
    Phillips TG, Slomiany WP, Allison R. Hair loss: common causes and treatment. Am Fam Physician. 2017;96(6):371–8. http://www.ncbi.nlm.nih.gov/pubmed/28925637. Accessed 13 Jan 2019.PubMedGoogle Scholar
  24. 24.
    Finner AM. Nutrition and hair. Dermatol Clin. 2013;31(1):167–72.  https://doi.org/10.1016/j.det.2012.08.015.CrossRefPubMedGoogle Scholar
  25. 25.
    Goldberg LJ, Lenzy Y. Nutrition and hair. Clin Dermatol. 2010;28(4):412–9.  https://doi.org/10.1016/J.CLINDERMATOL.2010.03.038.CrossRefPubMedGoogle Scholar
  26. 26.
    Ornstein RM, Fisher MM. Hormonal contraception in adolescents. Pediatr Drugs. 2006;8(1):25–45.  https://doi.org/10.2165/00148581-200608010-00003.CrossRefGoogle Scholar
  27. 27.
    Backman T, Huhtala S, Blom T, Luoto R, Rauramo I, Koskenvuo M. Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users. BJOG. 2000;107(3):335–9.  https://doi.org/10.1111/j.1471-0528.2000.tb13228.x.CrossRefPubMedGoogle Scholar
  28. 28.
    Paterson H, Clifton J, Miller D, Ashton J, Harrison-Woolrych M. Hair loss with use of the levonorgestrel intrauterine device. Contraception. 2007;76(4):306–9.  https://doi.org/10.1016/J.CONTRACEPTION.2007.06.015.CrossRefPubMedGoogle Scholar
  29. 29.
    Lullo JJ, Ethington E, Arshanapalli A, Reserva J, Jiang A, Adams W, et al. Incidence of androgenic dermatologic side effects following placement of a levonorgestrel intrauterine device for menorrhagia: a survey-based study. J Am Acad Dermatol. 2018;79(2):364–5.  https://doi.org/10.1016/J.JAAD.2017.12.051.CrossRefPubMedGoogle Scholar
  30. 30.
    Mirmirani P. Hormonal changes in menopause: do they contribute to a ‘midlife hair crisis’ in women? Br J Dermatol. 2011;165:7–11.  https://doi.org/10.1111/j.1365-2133.2011.10629.x.CrossRefPubMedGoogle Scholar
  31. 31.
    Lause M, Kamboj A, Fernandez Faith E. Dermatologic manifestations of endocrine disorders. Transl Pediatr. 2017;6(4):300–12.  https://doi.org/10.21037/tp.2017.09.08.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Samarasinghe S, Meah F, Singh V, Basit A, Emanuele N, Emanuele MA, et al. Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks. Endocr Pract. 2017;23(8):989.  https://doi.org/10.4158/EP171761.RA.CrossRefPubMedGoogle Scholar
  33. 33.
    Kempson IM, Lombi E. Hair analysis as a biomonitor for toxicology, disease and health status. Chem Soc Rev. 2011;40(7):3915.  https://doi.org/10.1039/c1cs15021a.CrossRefPubMedGoogle Scholar
  34. 34.
    Willimann B, Trüeb RM. Hair pain (Trichodynia): frequency and relationship to hair loss and patient gender. Dermatology. 2002;205(4):374–7.  https://doi.org/10.1159/000066437.CrossRefPubMedGoogle Scholar
  35. 35.
    Sulzberger M, Witten V, Kopf A. Diffuse alopecia in women. Its unexplained apparent increase in incidence. Arch Dermatol. 1960;81:556–60. http://www.ncbi.nlm.nih.gov/pubmed/13835674. Accessed 13 Jan 2019.CrossRefGoogle Scholar
  36. 36.
    Rebora A. Trichodynia: a review of the literature. Int J Dermatol. 2016;55(4):382–4.  https://doi.org/10.1111/ijd.13204.CrossRefPubMedGoogle Scholar
  37. 37.
    Baldari M, Montinari M, Guarrera M, Rebora A. Trichodynia is a distinguishing symptom of telogen effluvium. J Eur Acad Dermatol Venereol. 2009;23(6):733–4.  https://doi.org/10.1111/j.1468-3083.2009.03201.x.CrossRefPubMedGoogle Scholar
  38. 38.
    Kivanç-Altunay I, Savaş C, Gökdemir G, Köşlü A, Ayaydin EB. The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia. Int J Dermatol. 2003;42(9):691–3. http://www.ncbi.nlm.nih.gov/pubmed/12956679. Accessed 13 Jan 2019.CrossRefGoogle Scholar
  39. 39.
    Grimalt R, Ferrando J, Grimalt F. Trichodynia. Dermatology. 1998;196(3):374. http://www.ncbi.nlm.nih.gov/pubmed/9621162. Accessed 13 Jan 2019.PubMedGoogle Scholar
  40. 40.
    Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3:17011.  https://doi.org/10.1038/nrdp.2017.11.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Walker SA, Rothman S. A statistical study and consideration of endocrine influences. J Invest Dermatol. 1950;14(6):403–13.  https://doi.org/10.1038/jid.1950.52.CrossRefPubMedGoogle Scholar
  42. 42.
    Jang YH, Hong N-S, Moon SY, Eun DH, Lee WK, Chi SG, et al. Long-term prognosis of Alopecia Totalis and Alopecia Universalis: a longitudinal study with more than 10 years of follow-up: better than reported. Dermatology. 2017;233(2-3):250–6.  https://doi.org/10.1159/000477458.CrossRefPubMedGoogle Scholar
  43. 43.
    Saylam Kurtipek G, Cihan FG, Erayman Demirbaş Ş, Ataseven A. The frequency of autoimmune thyroid disease in alopecia areata and vitiligo patients. Biomed Res Int. 2015;2015:1–4.  https://doi.org/10.1155/2015/435947.CrossRefGoogle Scholar
  44. 44.
    Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 2015;8:397–403.  https://doi.org/10.2147/CCID.S53985.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Koo JY, Shellow WV, Hallman CP, Edwards JE. Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol. 1994;33(12):849–50. http://www.ncbi.nlm.nih.gov/pubmed/7883407. Accessed 14 Jan 2019.CrossRefGoogle Scholar
  46. 46.
    Chu S-Y, Chen Y-J, Tseng W-C, Lin MW, Chen TJ, Hwang CY, et al. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol. 2011;65(5):949–56.  https://doi.org/10.1016/j.jaad.2010.08.032.CrossRefPubMedGoogle Scholar
  47. 47.
    Garzorz N, Alsisi M, Todorova A, Atenhan A, Thomas J, Lauffer F, et al. Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseases. J Eur Acad Dermatol Venereol. 2015;29(12):2429–35.  https://doi.org/10.1111/jdv.13325.CrossRefPubMedGoogle Scholar
  48. 48.
    Ranawaka R. An observational study of alopecia areata in Sri Lankan adult patients. Ceylon Med J. 2014;59(4):128.  https://doi.org/10.4038/cmj.v59i4.7865.CrossRefPubMedGoogle Scholar
  49. 49.
    Yang S, Yang J, Liu JB, Wang HY, Yang Q, Gao M, et al. The genetic epidemiology of alopecia areata in China. Br J Dermatol. 2004;151(1):16–23.  https://doi.org/10.1111/j.1365-2133.2004.05915.x.CrossRefPubMedGoogle Scholar
  50. 50.
    Rebora A. Alopecia areata incognita: a hypothesis. Dermatology. 1987;174(5):214–8.  https://doi.org/10.1159/000249182.CrossRefGoogle Scholar
  51. 51.
    Tosti A, Whiting D, Iorizzo M, Pazzaglia M, Misciali C, Vincenzi C, et al. The role of scalp dermoscopy in the diagnosis of alopecia areata incognita. J Am Acad Dermatol. 2008;59(1):64–7.  https://doi.org/10.1016/j.jaad.2008.03.031.CrossRefPubMedGoogle Scholar
  52. 52.
    Lolli F, Pallotti F, Rossi A, Fortuna MC, Caro G, Lenzi A, et al. Androgenetic alopecia: a review. Endocrine. 2017;57(1):9–17.  https://doi.org/10.1007/s12020-017-1280-y.CrossRefPubMedGoogle Scholar
  53. 53.
    Hibberts NA, Howell AE, Randall VA. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol. 1998;156(1):59–65. http://www.ncbi.nlm.nih.gov/pubmed/9496234. Accessed 15 Jan 2019.CrossRefGoogle Scholar
  54. 54.
    Olsen EA. Female pattern hair loss. J Am Acad Dermatol. 2001;45(3 Suppl):S70–80. http://www.ncbi.nlm.nih.gov/pubmed/11511856.CrossRefGoogle Scholar
  55. 55.
    Rassman WR, Pak JP, Kim J. Phenotype of normal hairline maturation. Facial Plast Surg Clin North Am. 2013;21(3):317–24.  https://doi.org/10.1016/j.fsc.2013.04.001.CrossRefPubMedGoogle Scholar
  56. 56.
    Hibberts NA, Howell AE, Randall VA. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol. 1998;156(1):59–65.CrossRefGoogle Scholar
  57. 57.
    Rocha MA, Bagatin E. Skin barrier and microbiome in acne. Arch Dermatol Res. 2018;310(3):181–5.  https://doi.org/10.1007/s00403-017-1795-3.CrossRefPubMedGoogle Scholar
  58. 58.
    McDonough PH, Schwartz RA. Adolescent androgenic alopecia. Cutis. 2011;88(4):165–8.. http://www.ncbi.nlm.nih.gov/pubmed/22106721PubMedGoogle Scholar
  59. 59.
    Tosti A, Iorizzo M, Piraccini BM. Androgenetic alopecia in children: report of 20 cases. Br J Dermatol. 2005;152(3):556–9.  https://doi.org/10.1111/j.1365-2133.2004.06279.x.CrossRefPubMedGoogle Scholar
  60. 60.
    Rushton DH, Ramsay ID, Norris MJ, Gilkes JJ. Natural progression of male pattern baldness in young men. Clin Exp Dermatol. 1991;16(3):188–92.. http://www.ncbi.nlm.nih.gov/pubmed/1934570CrossRefGoogle Scholar
  61. 61.
    Dlova NC, Salkey KS, Callender VD, McMichael AJ. Central centrifugal Cicatricial Alopecia: new insights and a call for action. J Investig Dermatology Symp Proc. 2017;18(2):S54–6.  https://doi.org/10.1016/J.JISP.2017.01.004.CrossRefGoogle Scholar
  62. 62.
    Piérard-Franchimont C, De Doncker P, Cauwenbergh G, Piérard GE. Ketoconazole shampoo: effect of long-term use in Androgenic Alopecia. Dermatology. 1998;196(4):474–7.  https://doi.org/10.1159/000017954.CrossRefPubMedGoogle Scholar
  63. 63.
    Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015;3(2)  https://doi.org/10.13188/2373-1044.1000019.
  64. 64.
    Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, et al. Evidence-based (S3) guideline for the treatment of Androgenetic Alopecia in women and in men. J Dtsch Dermatol Ges. 2011;9:S1–S57.  https://doi.org/10.1111/j.1610-0379.2011.07802.x.CrossRefPubMedGoogle Scholar
  65. 65.
    DiMarco G, McMichael A. Hair loss myths. J Drugs Dermatol. 2017;16(7):690–4. http://www.ncbi.nlm.nih.gov/pubmed/28697221. Accessed 14 Jan 2019.PubMedGoogle Scholar
  66. 66.
    Giordano S, Romeo M, Lankinen P. Platelet-rich plasma for androgenetic alopecia: does it work? Evidence from meta analysis. J Cosmet Dermatol. 2017;16(3):374–81.  https://doi.org/10.1111/jocd.12331.CrossRefPubMedGoogle Scholar
  67. 67.
    Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62(4):489–96.  https://doi.org/10.1016/J.JOMS.2003.12.003.CrossRefPubMedGoogle Scholar
  68. 68.
    Schiavone G, Raskovic D, Greco J, Abeni D. Platelet-rich plasma for androgenetic alopecia. Dermatol Surg. 2014;40(9):1010–9.  https://doi.org/10.1097/01.DSS.0000452629.76339.2b.CrossRefPubMedGoogle Scholar
  69. 69.
    El Taieb MA, Ibrahim H, Nada EA, Seif Al-Din M. Platelets rich plasma versus minoxidil 5% in treatment of alopecia areata: a trichoscopic evaluation. Dermatol Ther. 2017;30(1):e12437.  https://doi.org/10.1111/dth.12437.CrossRefGoogle Scholar
  70. 70.
    Garg S, Manchanda S. Platelet-rich plasma-an “Elixir” for treatment of alopecia: personal experience on 117 patients with review of literature. Stem Cell Investig. 2017;4:64.  https://doi.org/10.21037/sci.2017.06.07.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Fakahany H, Raouf HMW. Using automated microneedling with platelet rich plasma for treating cicatricial alopecia, recalcitrant alopecia areata and traction alopecia, case report. J Am Acad Dermatol. 2016;74(5):AB140.  https://doi.org/10.1016/J.JAAD.2016.02.551.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Brandon Burroway
    • 1
  • Jacob Griggs
    • 1
  • Antonella Tosti
    • 2
    Email author
  1. 1.Dr. Phillip Frost Department of Dermatology and Cutaneous SurgeryUniversity of Miami, Leonard M. Miller School of MedicineMiamiUSA
  2. 2.Fredric Brandt Endowed Professor of Dermatology, Dr. Phillip Frost Department of Dermatology and Cutaneous SurgeryUniversity of Miami Miller School of MedicineMiamiUSA

Personalised recommendations